×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

GSKCH plans to bring global products into India

GSKCH plans to bring global products into India
PTI
Comment E-mail Print Share
First Published: Thu, Jan 31 2008. 02 25 PM IST
Updated: Thu, Jan 31 2008. 02 25 PM IST
New Delhi: GlaxoSmithKline Consumer Healthcare (GSKCH) said on Thursday it plans to introduce some of its global brands, including toothpaste Sensodyne, into India in the next three years to strengthen its position in the health and nutrition market here.
The company also announced its foray into the fast growing specialist nutrition category.
“Ours is a three-pronged strategy to grow in India. While we will continue to grow the flagship product Horlicks into a mega brand concept, we will also be bringing global brands in India and roll out speciality nutrition products,” said Zubair Ahmed, managing director, GSKCH.
He said GSKCH would be adding more variety to its Rs1,000-crore brand Horlicks, like the ‘Women’s Horlicks´ introduced recently, to make it a mega brand.
“The second part of the strategy is to get existing products from global portfolio such as toothpaste Sensodyne, vitamin drink Ribena and other smoking cessation products in a phased manner over a three year period,” Ahmed added.
Also brands like energy drink ‘Lucozade´ and nasal strip and snore relief product ‘Breathe Right´ could also be finding their way to India, but are subject to regulatory approval, he said. Also, some of the global products have to be modified to suit the local regulatory conditions.
GSKCH on Thursday announced its foray into the speciality nutrition category as the third part of its overall strategy by launching protein supplement ‘ActiBase´.
”We see a big potential in this segment, which is currently estimated to be around Rs600 crore. We will be introducing several niche products under this umbrella,“ Ahmed said.
The new product was developed entirely in India to suit the local taste and in due course of time it may find its way into the export market, he added.
“ActiBase is not a mass product and is available only through doctor’s prescription,” he said.
Targeting young and adults, the product would be introduced in a phased manner from bigger cities to smaller ones, he added.
The company, which had earlier said it was looking for merger and acquisition opportunities in the Indian market is till looking out for the right target, he said, but added finding the right target was proving to be a challenge.
Comment E-mail Print Share
First Published: Thu, Jan 31 2008. 02 25 PM IST
More Topics: Gskch | India | Sensodyne | Horlicks | Zubair Ahmed |